[
    [
        {
            "time": "",
            "original_text": "格隆汇港股聚焦(9.11)︱佳兆业前8月销售443亿元 星美文化旅游拟收购270多家影院",
            "features": {
                "keywords": [
                    "佳兆业",
                    "销售",
                    "443亿元",
                    "星美文化",
                    "旅游",
                    "收购",
                    "影院"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "房地产",
                    "娱乐"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "格隆汇港股聚焦(9.11)︱佳兆业前8月销售443亿元 星美文化旅游拟收购270多家影院",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "上海医药(02607.HK)控股股东上实集团增持30万股H股",
            "features": {
                "keywords": [
                    "上海医药",
                    "上实集团",
                    "增持",
                    "30万股",
                    "H股"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "上海医药(02607.HK)控股股东上实集团增持30万股H股",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "复旦张江(01349.HK)与上海医药订立销售及分销协议",
            "features": {
                "keywords": [
                    "复旦张江",
                    "上海医药",
                    "销售",
                    "分销协议"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "复旦张江(01349.HK)与上海医药订立销售及分销协议",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        }
    ]
]